Where we come from
Although firmly rooted in Germany, today we are very much a growing global business. As an integrated research and development company, we have a strong track record of bringing pain treatments to patients.
Grünenthal Ltd., UK, a subsidiary of Grünenthal GmbH, was established in 2004.
With headquarters in TOR Buildings, Saint-Cloud Way, Maidenhead SL6 8BN, the company includes Regulatory, Medical Information, Sales and Marketing divisions as well as Market Access and Medical Science Liaison teams.
2014 Recivit® (fentanyl) & Palexia® (tapentadol oral solution) Launch
M-ALL-UK-01-24-0004 - January 2024